Literature DB >> 19665472

The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.

Fiorella Tonello1, Cesare Montecucco.   

Abstract

The anthrax lethal factor is a multi-domain protein toxin released by Bacillus anthracis which enters cells in a process mediated by the protective antigen and specific cell receptors. In the cytosol, the lethal factor cleaves the N-terminal tail of many MAPK kinases, thus deranging a major cell signaling pathway. The structural features at the basis of these activities of LF are reviewed here with particular attention to the proteolytic activity and to the identification of specific inhibitors. A significant similarity between the metalloprotease domain of the lethal factor and of that of the clostridial neurotoxins has been noted and is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665472     DOI: 10.1016/j.mam.2009.07.006

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  41 in total

Review 1.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

2.  Polymorphic toxin systems: Comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics.

Authors:  Dapeng Zhang; Robson F de Souza; Vivek Anantharaman; Lakshminarayan M Iyer; L Aravind
Journal:  Biol Direct       Date:  2012-06-25       Impact factor: 4.540

Review 3.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

Review 4.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

5.  NLRP1 is an inflammasome sensor for Toxoplasma gondii.

Authors:  Sarah E Ewald; Joseph Chavarria-Smith; John C Boothroyd
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

6.  Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.

Authors:  Xiangyang Chi; Jianmin Li; Weicen Liu; Xiaolin Wang; Kexin Yin; Ju Liu; Xiaodong Zai; Liangliang Li; Xiaohong Song; Jun Zhang; Xiaopeng Zhang; Ying Yin; Ling Fu; Junjie Xu; Changming Yu; Wei Chen
Journal:  Clin Vaccine Immunol       Date:  2015-03-18

Review 7.  Designing inhibitors of anthrax toxin.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Expert Opin Drug Discov       Date:  2014-01-22       Impact factor: 6.098

Review 8.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

9.  Global metabolomic analysis of a mammalian host infected with Bacillus anthracis.

Authors:  Chinh T Q Nguyen; Vivekananda Shetty; Anthony W Maresso
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

10.  A bacteriophage-based platform for rapid trace detection of proteases.

Authors:  Petr Capek; Killeen S Kirkconnell; Tobin J Dickerson
Journal:  J Am Chem Soc       Date:  2010-09-29       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.